Aptevo Therapeutics Inc. (APVO) — Institutional Holders, Q2 2026
9 institutional investment managers reported a APVO position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $224.3K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
APVO in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
New positions
1
Added to
1
Trimmed
2
Sold out
0
Biggest buyers
- GSA CAPITAL PARTNERS LLPAdded · +1,901 sh+$8.4K
- BARCLAYS PLCNew · +31 sh+$138.00
Biggest sellers
- UBS Group AGTrimmed · -2,715 sh-$12.1K
- GEODE CAPITAL MANAGEMENTTrimmed · -2,516 sh-$11.2K
APVO 13F holders ranked 1–9 of 9
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | GSA CAPITAL PARTNERS LLP#1 · 21,539 sh | 21,539 | $96.0K | <0.01% | +9.7% |
| 2 | VANGUARD CAPITAL MANAGEMENT#2 · 12,713 sh | 12,713 | $56.4K | 0.00% | 0.0% |
| 3 | GEODE CAPITAL MANAGEMENT#3 · 10,821 sh | 10,821 | $48.0K | 0.00% | -18.9% |
| 4 | VANGUARD FIDUCIARY#4 · 4,142 sh | 4,142 | $18.4K | 0.00% | 0.0% |
| 5 | UBS Group AG#5 · 730 sh | 730 | $3.2K | 0.00% | -78.8% |
| 6 | OSAIC#6 · 360 sh | 360 | $1.6K | 0.00% | 0.0% |
| 7 | SBI Securities , Ltd.#7 · 109 sh | 109 | $484.00 | — | 0.0% |
| 8 | BARCLAYS PLC#8 · 31 sh | 31 | $138.00 | 0.00% | New |
| 9 | DANSKE BANK A/S#9 · 1 sh | 1 | $4.00 | 0.00% | 0.0% |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.